000 01319 a2200361 4500
005 20250516101409.0
264 0 _c20130104
008 201301s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0039706
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBangsgaard, Nannie
245 0 0 _aNeutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor.
_h[electronic resource]
260 _bPloS one
_c2012
300 _ae39706 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInterleukin-8
_ximmunology
650 0 4 _aNeutralization Tests
650 0 4 _aSkin Diseases
_xchemically induced
700 1 _aHoutkamp, Mischa
700 1 _aSchuurhuis, Danita H
700 1 _aParren, Paul W H I
700 1 _aBaadsgaard, Ole
700 1 _aNiessen, Hans W M
700 1 _aSkov, Lone
773 0 _tPloS one
_gvol. 7
_gno. 6
_gp. e39706
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0039706
_zAvailable from publisher's website
999 _c21918018
_d21918018